Dosing interval is a major factor determining the quality of T cells induced by SARS-CoV-2 mRNA and adenoviral vector vaccines.
Murray SM. et al, (2025), Sci Immunol, 10
Immunogenicity and Safety of ChAdOx1 nCoV-19 (AZD1222) as a Homologous Fourth-Dose Booster: A Substudy of the Phase 3 COV003 Trial in Brazil.
Costa Clemens SA. et al, (2025), Mayo Clin Proc Innov Qual Outcomes, 9
A vaccine emergency – when to overrule parental refusal of vaccination at birth for prevention of vertical transmission of hepatitis B virus?
Basu Roy R. et al, (2025), Archives of Disease in Childhood
Salmonella Typhi gut invasion drives hypoxic immune subsets associated with disease outcomes.
Bossel Ben-Moshe N. et al, (2025), Nat Commun, 16
Age differences in immunity to human seasonal coronaviruses and the immunogenicity of ChAdOx1 nCoV-19 (AZD1222).
Belij-Rammerstorfer S. et al, (2025), EBioMedicine, 118
Prediction and characterisation of the human B cell response to a heterologous two-dose Ebola vaccine.
O'Connor D. et al, (2025), Nat Commun, 16
Antibiotic use attributable to RSV infections during infancy - an international prospective birth cohort study
Hak SF. et al, (2025), Journal of Antimicrobial Chemotherapy, 80, 1803 - 1812
Respiratory viral detection in children hospitalized with pneumonia during periods of major population disruptions in Nepal, 2014-2018.
Shrestha S. et al, (2025), J Pediatric Infect Dis Soc
The waning of maternal measles antibodies: a multi-country maternal-infant seroprevalence study.
Tiley KS. et al, (2025), J Infect
Adenoviral-vectored vaccine against Bordetella pertussis fimbrial antigen induces partial protection in a mouse model
Dierig A. et al, (2025), Vaccine X, 24
The TyphiNET data visualisation dashboard: unlocking Salmonella Typhi genomics data to support public health.
Dyson ZA. et al, (2025), Genome Med, 17
A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccine.
Dold C. et al, (2025), Sci Transl Med, 17
Consultation report - considerations for a regulatory pathway for bivalent Salmonella Typhi/Paratyphi A vaccines for use in endemic countries.
Ibarz-Pavon AB. et al, (2025), Vaccine, 56
Risk analysis for outpatient experimental infection as a pathway for affordable RSV vaccine development.
Siegal EZ. et al, (2025), NPJ Vaccines, 10
A 5-transcript signature for discriminating viral and bacterial etiology in pediatric pneumonia.
Viz-Lasheras S. et al, (2025), iScience, 28
Pneumococcal Carriage and Disease in Adults in England, 2011-2019: The Importance of Adults as a Reservoir for Pneumococcus in Communities.
El Safadi D. et al, (2025), J Infect Dis, 231, e17 - e27